Loading...

PODCAST

Lab to Lives

Ivanna Rosendal

A simple question started this show: How do we medicine from the lab to making a difference in people"s lives as quickly as possible?The answers are complex. Actual solutions are hard to come by. We want to distill ideas until we see actual impact in the industry.Our three hosts all have backgrounds in life sciences and in improv comedy. Together, with their guests, they"re on a mission to have conversations that can have an impact. And have some fun along the way.

science life sciences

All Episodes

36:08

Data Governance in the Age of Generative AI with...

Lab to Lives ·

2025/06/04

Send us a text Sebastian Andruszczak, Chief Growth Officer at Holisticon (part of the Nexer Group), brings fresh perspective to the conversation around generative AI adoption in pharmaceutical companies. Drawing from his unique background in sales, marketing, and technology, Sebastian cuts through the hype to address fundamental challenges that prevent successful AI implementation in life sciences. The conversation reveals a critical insight often overlooked in the rush to adopt new technolo...

en-gb

27:14

Prevention Pays: How Technology Is Revolutionizing...

Lab to Lives ·

2025/05/21

Send us a text Why do we wait until we're severely unwell before seeking help? In this thought-provoking episode, I'm joined by Eva Papadopoulou, a mental health professional and expert in digital and AI-enabled healthcare solutions, to explore the transformative potential of preventative mental healthcare. Eva reveals the stark reality of our current healthcare systems - less than 10% of budgets are allocated to prevention, despite evidence showing preventative approaches lead to better out...

en-gb

45:14

Creating virtuous cycles in drug development with Rob...

Lab to Lives ·

2025/04/23

Send us a text Rob Freistat, President of Uncommon Cures, discusses how clinical trials are transforming to accelerate drug development and ensure patients receive treatments faster, particularly in the rare disease space. • Current market uncertainty and investment challenges in biotech, especially for rare disease research • Approximately two-thirds of clinical trial processes add no value and aren't required by regulations • Many clinical trial failures occur not because drugs don't work ...

en-gb

32:03

Bridging Academia and Biotech: Creating Innovators of...

Lab to Lives ·

2025/04/09

Send us a text Jonathan Hill takes us on a fascinating journey through the cutting-edge world of DNA sequencing and its revolutionary potential for early disease detection. As both an academic professor at Brigham Young University and co-founder of Wasatch BioLabs, Hill shares how third-generation sequencing technologies are transforming our ability to identify diseases years before symptoms appear. The conversation centers on a groundbreaking approach using native methylation calling—a meth...

en-gb

56:22

From Lab to Patient: Why Vector Design Makes or...

Lab to Lives ·

2025/03/26

Send us a text Vectors are the unsung heroes of cell and gene therapy—molecular couriers that transport therapeutic genes into human cells to treat disease. But as Alan Griffith, Head of Global Operations at Vector Builder reveals, creating these sophisticated delivery vehicles is far more complex than most realize. Drawing from over a decade of experience developing gene therapies before joining the CDMO sector, Griffith offers rare insight into what makes manufacturing these therapies so c...

en-gb

24:18

Tomorrow's Cures Are Hiding in Today's Patient...

Lab to Lives ·

2025/03/12

Send us a text The untapped potential of electronic health records has long been recognized in clinical research, but extracting meaningful insights from this treasure trove of data has remained an elusive challenge—until now. Vish Srivastava, founder of Century Health, reveals how artificial intelligence is revolutionizing real-world evidence by unlocking critical patient data trapped in EHRs. Traditional patient registries that once took a decade to amass just 1,000 patients can now be cre...

en-gb

32:07

Championing Diversity to Transform Clinical Research...

Lab to Lives ·

2025/02/26

Send us a text Join us for a conversation with guest Shelli Pavone, co-founder of Inlightened, to uncover the untapped potential of diversity in clinical trials. Discover how historical mistrust, structural barriers, and exclusion criteria continue to hinder diverse patient recruitment. Shelli sheds light on the transformative impact inclusive trials have on scientific integrity, safety, and the generalizability of results. By embracing diversity, not only do we align with regulatory expectat...

en-gb

56:23

Revolutionizing Neurological Care: Andreas Forsland...

Lab to Lives ·

2025/02/12

Send us a text In this episode we dive into Brain-Computer Interface (BCI) technology, where the brain's faint signals are harnessed to create life-changing applications. Andreas Forsland and Greg Johns emphasize the importance of community-driven innovation, guided by the Brainiac Council—a unique assembly of patients, caregivers, and experts. This collaborative approach ensures that the solutions developed address real-world challenges, improving communication and independence for those wit...

en-gb

29:08

Revolutionizing Patient Recruitment in Clinical...

Lab to Lives ·

2025/01/22

Send us a textThis episode reveals alarming statistics about patient access to clinical trials, highlighting that only 3% of patients currently have access to participate. Our guest, Jill Pellegrino, CEO of Auto Recruitment, shares innovative strategies to engage the other 90% of the patient population and discusses the importance of digital advertising, pre-screening, and patient support in the recruitment process.• Discussion on the low percentage of patient access to clinical trials •...

en-gb

34:59

Navigating the Shift: From SAS to R in Clinical...

Lab to Lives ·

2024/11/20

Send us a textWhy has SAS been the cornerstone of clinical trials for decades, and what is causing the shift to R now? Join us on "Transformation in Trials" as we explore this pivotal transition with Sunil Gupta, a seasoned programmer who has navigated both worlds. Sunil elaborates on SAS's long-standing dominance due to its robust programming capabilities and ease of use for FDA reviewers. However, the landscape is changing as R garners attention for its graphical prowess and collaborative p...

en-gb

47:18

Enhancing Vendor Oversight and Communication...

Lab to Lives ·

2024/11/13

Send us a textPrepare to transform your understanding of vendor oversight in clinical trials as we welcome Jessica Cordes, a senior consultant and trainer at the Clinical Excellence Consultancy. Jessica brings her wealth of experience to highlight the intricate responsibilities that sponsors must navigate when outsourcing tasks. Our conversation promises to equip you with insights on maintaining control, mitigating risks, and leveraging technology like AI and machine learning to future-proof ...

en-gb

34:42

Navigating Cell and Gene Therapy: Insights and...

Lab to Lives ·

2024/08/06

Send us a Text Message.How do you navigate the complexities of manufacturing cell and gene therapies that are tailored to individual patients? Find out as we sit down with Dr. Bruce Levine from the University of Pennsylvania to unpack the intricacies of clinical research in this groundbreaking field. From the unique emphasis on chemistry, manufacturing, and controls (CMC) to the logistical hurdles of sourcing and modifying patient-derived cells, Dr. Levine offers an expert's perspective on th...

en-gb

40:53

Reconnecting with Purpose: Transforming Job...

Lab to Lives ·

2024/07/17

Send us a Text Message.What if re-engaging with your purpose could revolutionize your job satisfaction and mental health? Join us for our conversation with Jill Donahue, a leader in life sciences whose personal journey through psychology, behavioral science, and a profound personal tragedy has fueled her mission to improve communication and trust within the healthcare community. Jill opens up about how these experiences led her to create initiatives like her book "A Dose of Inspiration" and t...

en-gb

29:40

Revolutionizing Clinical Trials: The Promise of AI...

Lab to Lives ·

2024/07/10

When nine out of ten clinical trials don't cross the finish line, it's time to ask tough questions and seek innovative answers. That's exactly the journey we embark on with Vinodh Balaraman from KolateAI in our latest podcast episode. Together, we unravel the complex knot of challenges that lead to clinical trial failures, from flawed study designs to enrollment obstacles and the unexpected curveballs thrown by the approval of competitor drugs. But it's not all doom and gloom; we shine a ligh...

en-gb

38:24

Exploring Patient-Centric Innovations in Digestive...

Lab to Lives ·

2024/05/28

Navigating the tumultuous sea of inflammatory bowel disease (IBD) is no small feat, and Ariadna Maso of Sanno Health is our compass on this voyage. As the mastermind behind a company that's reshaping how we understand and manage gut health, Ari shares her intimate understanding of the patient's struggle, from the stinging uncertainty of diagnosis to the often overlooked psychological toll. Our conversation goes beyond the standard medication narrative and into the realm of holistic care, wher...

en-gb

34:17

Large Language Models in Clinical Trials with Eirini...

Lab to Lives ·

2024/04/03

en-gb

33:13

The Evolution of Clinical Trials Through Wearable...

Lab to Lives ·

2024/03/27

en-gb

67:03

Innovating Clinical Trial Design with Pierre Colin...

Lab to Lives ·

2024/03/13

en-gb

36:36

Mastering the Art of Clinical Trial Partnerships:...

Lab to Lives ·

2024/03/06

en-gb

41:34

Breaking Barriers for Diversity in Clinical Trials...

Lab to Lives ·

2024/02/28

en-gb

98 results

Similar Podcasts

The Deep Dive Lab: Unraveling Materials Science

Son Hoang

New Books in Political Science

New Books Network

Station 151

Pale Matter | Realm

Beyond the Divide

Koala Moon

StarTalk with Neil deGrasse Tyson

Neil deGrasse Tyson